Indications and uses
Temporary relief of dry irritated nasal passages Promotes healthy nasal passages Clears and invigorates breathing
Vortex Moisturizer Nasal Spray
- Manufacturer
- Vortex Life Sciences, Inc.
- Effective date
- 2022-03-07
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 1
- Source
- full-release
- Hydrated at
- 2026-05-31 23:48:37
Label at a glance#
ProductVortex Moisturizer Nasal
Active ingredientSODIUM CHLORIDE
Label structure7 sections
Dosage and administration
Sniff and inhale deeply while spraying into nostril. 12 years old - adult: 3 sprays in each nostril. 6 - 12 years old: 2 sprays in each nostril. 3 - 6 years old: 1 spray in each nostril. Children under age 3: 1 spray. Consult a physician. To use, remove cap, insert the nozzle into the nostril and depress the pump completely while sniffing deeply. Day 1: every 3 hours, minimum 5 doses/day Day 2: every 3 hours, mini...
Contacts and useful links#
Label contents#
Full prescribing information#
Active Ingredients:
Sodium Chloride 0.65%
Purpose:
Moisturizer
Inactive Ingredient:
Purified mineral water
Uses
Temporary relief of dry irritated nasal passages
Promotes healthy nasal passages
Clears and invigorates breathing
Directions:
Sniff and inhale deeply while spraying into nostril.
12 years old
- adult: 3 sprays in each nostril.
6 - 12 years old: 2 sprays in each nostril.
3 - 6 years old: 1 spray in each nostril.
Children under age 3: 1 spray. Consult a
physician.
To use, remove cap, insert the nozzle into
the nostril and depress the pump completely
while sniffing deeply.
Day 1: every 3 hours, minimum 5 doses/day
Day 2: every 3 hours, minimum 5 doses/day
Day 3: 3 times a day.
Day 4: at bedtime.
Day 5: at bedtime.
Day 6 - 9: skip.
Day 10: Final dose at bedtime.
For moderate to severe symptoms every 3 hours (minimum 5 doses/24 hrs) until symptoms have significantly reduced. Then,
resume at day 3 schedule.
WARNING:
Use only as directed.
If pregnant or breastfeeding,
consult with a physician before use.
Keep out of reach of children.
Stop use and consult with a physician
if you experience any discomfort while using this product.
In case of overdose, get medical help or contact a Poison Control Center at 1-800-222-2222 right away.
Other Information:
Store and use at room temperature Inspect bottle for integrity Do not use if safety seal is broken
Package Labeling:
DailyMed RxNorm Mappings#
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 82529-000-01 | 2024-01-30 | C162847 | 48780-1 | 1030e365-522b-111a-e063-dadaa90a10e2 | Vortex Moisturizer Nasal Spray |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 82529-000-01 | Vortex Moisturizer Nasal | 15 mL in 1 BOTTLE | LIQUID | 15 | 1 | |
| 82529-000-01 | Vortex Moisturizer Nasal | 1 in 1 BOX | LIQUID | 1 | 1 |
DailyMed Dashboard NDC Coverage#
Products#
Every source-derived product name is available through these pages.
- Vortex Moisturizer Nasal
- SODIUM CHLORIDE
- WATER
- CHLORIDE ION
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 82529-000 | 82529-000-01 |
Ingredients#
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| WATER | 059QF0KO0R | IACT |
| SODIUM CHLORIDE | 451W47IQ8X | ACTIB |
Source Document#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| d9a1828b-0288-0a20-e053-2a95a90a4838 | d87f20d6-933f-4419-b035-e307a13a60aa | 2022-03-07 | Warnings | d9a1828b-0288-0a20-e053-2a95a90a4838 d87f20d6-933f-4419-b035-e307a13a60aa |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.